Generation of Human-Induced Pluripotent Stem Cells by a Nonintegrating RNA Sendai Virus Vector in Feeder-Free or Xeno-Free Conditions
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The generation of induced pluripotent stem cells (iPSCs) from somatic cells has enabled the possibility of providing unprecedented access to patient-specific iPSC cells for drug screening, disease modeling, and cell therapy applications. However, a major obstacle to the use of iPSC for therapeutic applications is the potential of genomic modifications caused by insertion of viral transgenes in the cellular genome. A second concern is that reprogramming often requires the use of animal feeder layers and reagents that contain animal origin products, which hinder the generation of clinical-grade iPSCs. Here, we report the generation of iPSCs by an RNA Sendai virus vector that does not integrate into the cells genome, providing transgene-free iPSC line. In addition, reprogramming can be performed in feeder-free condition with StemPro hESC SFM medium and in xeno-free (XF) conditions. Generation of an integrant-free iPSCs generated in xeno-free media should facilitate the safe downstream applications of iPSC-based cell therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Takahashi and Yamanaka first demonstrated that induced pluripotent stem cells (iPSCs) can be generated from somatic cells by transducing four transcription factors using retroviral vectors [1, 2].”
BackgroundInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · cited 1×
“Sendai virus vector is the ease of use with single transduction comparing to other methods that require multiple transfections [29].”
BackgroundA more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441 · cited 2×
“…by a Nonintegrating RNA Sendai Virus Vector in Feeder-Free or Xeno-Free Conditions Chad C. MacArthur,1 Andrew Fontes,1 Namritha Ravinder,2 David Kuninger,1 Jasmeet Kaur,1 Matthew Bailey,1 Antje Taliana,2 Mohan C. Vemuri,3 and Pauline T. Lieu1 1 Primary and Stem Cell Systems, Life Technologies…”
BackgroundInfluentialFUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411 · cited 3×
“12344040) with the following primers to detect for the presence of Sendai virus vector (SeV: Frw: GGATCACTAGGTGATATCGAGC, Rev: ACCAGACAAGAGTTTAAGAGATATGTATC) as described in [19].”
BackgroundMethod
Cited by
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Omole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
“Another non-integrating viral vector that has been successfully used for iPSC generation is the Sendai virus (SeV) (Fusaki et al., 2009; Seki et al., 2010; Ban et al., 2011; Nishishita et al., 2012;Ono et al., 2012; Seki, Yuasa & Fukuda, 2012;Macarthur et al., 2012).”
MethodFeeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
Al Abbar, A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0046 · Cited by 134
Haridhasapavalan, K. K., Borgohain, M. P., Dey, C., Saha, B., Narayan, G., Kumar, S., & Thummer, R. P. (2019) · Gene · doi:10.1016/j.gene.2018.11.069 · Cited by 115
Technological Overview of iPS Induction from Human Adult Somatic Cells
Bayart, E., & Cohen-Haguenauer, O. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020002 · Cited by 113
All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0620 · Cited by 105
Li, L., Wang, Y., Torkelson, J. L., Shankar, G., Pattison, J. M., Zhen, H. H., Fang, F., Duren, Z., Xin, J., Gaddam, S., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.012 · Cited by 93
Borgohain, M. P., Haridhasapavalan, K. K., Dey, C., Adhikari, P., & Thummer, R. P. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9861-6 · Cited by 89
Kang, X., Yu, Q., Huang, Y., Song, B., Chen, Y., Gao, X., He, W., Sun, X., & Fan, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131128 · Cited by 86
Lu, H., Chai, C., Lim, T. C., Leong, M. F., Lim, J. K., Gao, S., Lim, K., & Wan, A. C. A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.050 · Cited by 80
Alves, C. J., Dariolli, R., Jorge, F. M. H., Monteiro, M. R., Maximino, J. R., Martins, R. S., Strauss, B. E., Krieger, J. E., Callegaro, D., & Chadi, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00289 · Cited by 78
Generation of pluripotent stem cells without the use of genetic material
Higuchi, A., Ling, Q., Kumar, S. S., Munusamy, M. A., Alarfaj, A. A., Chang, Y., Kao, S.-H., Lin, K.-C., Wang, H.-C., & Umezawa, A. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.132 · Cited by 78
Goh, P. A., Caxaria, S., Casper, C., Rosales, C., Warner, T. T., Coffey, P. J., & Nathwani, A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081622 · Cited by 67
A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S. A., Veivers, D., Sue, C. M., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010884 · Cited by 59
Revilla, A., González, C., Iriondo, A., Fernández, B., Prieto, C., Marín, C., & Liste, I. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2021 · Cited by 59
Human neural progenitors derived from integration-free iPSCs for SCI therapy
Liu, Y., Zheng, Y., Li, S., Xue, H., Schmitt, K., Hergenroeder, G. W., Wu, J., Zhang, Y., Kim, D., & Cao, Q. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.01.004 · Cited by 53
Induced Pluripotent Stem Cells as a Source of Hepatocytes
Sauer, V., Roy-Chowdhury, N., Guha, C., & Roy-Chowdhury, J. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-013-0039-2 · Cited by 52
Maddah, M., Shoukat-Mumtaz, U., Nassirpour, S., & Loewke, K. E. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068214537258 · Cited by 48
Hepatocyte-like cells derived from induced pluripotent stem cells
Roy‐Chowdhury, N., Wang, X., Guha, C., & Roy‐Chowdhury, J. (2016) · Hepatology International · doi:10.1007/s12072-016-9757-y · Cited by 46
Kim, K., Gil, M., Dayem, A. A., Choi, S., Kang, G., Yang, G., Cho, S., Jeong, Y., Kim, S., Seok, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030827 · Cited by 44
Sung, T., Li, H.-F., Higuchi, A., Kumar, S. S., Ling, Q., Wu, Y., Burnouf, T., Nasu, M., Umezawa, A., Lee, K., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119638 · Cited by 41
Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies
Foltz, L. P., & Clegg, D. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.09.002 · Cited by 39
Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA
Connor, B. J., Firmin, E., McCaughey‐Chapman, A., Monk, R., Lee, K. C., Liot, S., Geiger, J. P., Rudolph, C., & Jones, K. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00918 · Cited by 39
Mormone, E., D'Sousa, S., Alexeeva, V., Bederson, M. M., & Germano, I. M. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0151 · Cited by 39
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24–28].”
MethodHuman iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications
Cefalo, M. G., Carai, A., Miele, E., Pò, A., Ferretti, E., Mastronuzzi, A., & Germano, I. M. (2015) · Stem Cells International · doi:10.1155/2016/4869071 · Cited by 35
Bazley, F. A., Liu, C. F., Yuan, X., Hao, H., All, A. H., Angeles, A. D. L., Zambidis, E. T., Gearhart, J. D., & Kerr, C. L. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0100 · Cited by 32
Melanocytes Derived from Transgene-Free Human Induced Pluripotent Stem Cells
Jones, J. C., Sabatini, K., Liao, X., Tran, H. T. T., Lynch, C. L., Morey, R. E., Glenn-Pratola, V., Boscolo, F. S., Yang, Q., Parast, M. M., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.139 · Cited by 31
Induced pluripotent stem cells and their implication for regenerative medicine
Csöbönyeiová, M., Polák, Š., Koller, J., & Danišovič, Ľ. (2014) · Cell and Tissue Banking · doi:10.1007/s10561-014-9462-9 · Cited by 30
A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
Matiukhova, M., Ryapolova, A., Andriianov, V. S., Reshetnikov, V. V., Zhuravleva, S., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593207 · Cited by 30
Lin, Y., Liu, H., Klein, M. G., Ostrominski, J. W., Hong, S. G., Yada, R. C., Chen, G., Navarengom, K., Schwartzbeck, R., San, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24074-y · Cited by 29
Chang, W. Y., Lavoie, J. R., Kwon, S. Y., Chen, Z., Manias, J. L., Behbahani, J., Ling, V., Kandel, R. A., Stewart, D. J., & Stanford, W. L. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.11.006 · Cited by 29
Pushp, P., Nogueira, D. E. S., Rodrigues, C. A. V., Ferreira, F. C., Cabral, J. M. S., & Gupta, M. K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10061-2 · Cited by 27
Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 25
Tan, L. S., Chen, J. T., Lim, L. Y., & Teo, A. K. K. (2022) · Cell Proliferation · doi:10.1111/cpr.13232 · Cited by 25
Recent advances in the induced pluripotent stem cell‐based skin regeneration
Choudhury, S., Surendran, N., & Das, A. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12925 · Cited by 25
Dey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P. (2021) · Recent Advances in iPSC Technology · doi:10.1016/b978-0-12-822231-7.00011-4 · Cited by 23
Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances
McCaughey‐Chapman, A., & Connor, B. J. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0122 · Cited by 23
Novosadova, E. V., & Grivennikov, I. A. (2014) · Biochemistry (Moscow) · doi:10.1134/s000629791413001x · Cited by 23
Ting, H.-C., Yang, H.-I., Harn, H., Chiu, I., Su, H., Li, X., Chen, M., Ho, T., Liu, C.-A., Tsai, Y.-J., et al. (2021) · Cells · doi:10.3390/cells10102773 · Cited by 22
Induced Pluripotent Stem Cells as Vasculature Forming Entities
Palladino, A., Mavaro, I., Pizzoleo, C., Felice, E. D., Lucini, C., de Girolamo, P., Netti, P. A., & Attanasio, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111782 · Cited by 18
Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders
Qin, Y., & Gao, W. (2015) · Stem Cells · doi:10.1002/stem.2112 · Cited by 17
Direct Generation of Human Cortical Organoids from Primary Cells
Schukking, M., Miranda, H. C., Trujillo, C. A., Negraes, P. D., & Muotri, A. R. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0112 · Cited by 16
Srijaya, T. C., Sriram, S., Subramanian, S., Cheng, S., Ong, W. K., Rozen, S., Kasim, N. H. A., & Sugii, S. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0796-2 · Cited by 15
Kishino, Y., Seki, T., Yuasa, S., Fujita, J., & Fukuda, K. (2015) · Journal of Visualized Experiments · doi:10.3791/53225 · Cited by 14
Genova, E. C., Cavion, F., Lucafò, M., Pelin, M., Lanzi, G., Masneri, S., Ferraro, R. M., Fazzi, E. M., Orcesi, S., Decorti, G., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1837 · Cited by 14
Quang, T., Marquez, M., Blanco, G., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086031 · Cited by 14
Induced Pluripotent Stem Cells: Progress and Future Perspectives in the Stem Cell World
Rezanejad, H., & Matin, M. M. (2012) · Cellular Reprogramming · doi:10.1089/cell.2012.0039 · Cited by 13
Fiedorowicz, K., Rozwadowska, N., Zimna, A., Malcher, A., Tutak, K., Szczerbal, I., Nowicka-Bauer, K., Nowaczyk, M., Kolanowski, T. J., Łabędź, W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58050-2 · Cited by 12
Ting, H.-C., Su, H., Chen, M., Harn, H., Lin, S., Chiou, T., & Chang, C.-Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113462 · Cited by 12
Vosough, M., Ravaioli, F., Zabulica, M., Capri, M., Garagnani, P., Franceschi, C., Piccand, J., Kraus, M. R.-C., Kannisto, K., Gramignoli, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215490 · Cited by 10
Ting, H.-C., Guo, Y., Su, H.-L., Chen, Y.-S., Lin, S., Harn, H., & Chang, C.-Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02302-5 · Cited by 10
Drouin‐Ouellet, J. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.26 · Cited by 9
Sfougataki, I., Grafakos, I., Varela, I., Mitrakos, A. K., Karagiannidou, A., Tzanoudaki, M., Poulou, M., Mertzanian, A., Roubelakis, M. G., Stefanaki, K., et al. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.01.003 · Cited by 6
Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application
Avaca, M. J., & Gruh, I. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_24 · Cited by 6
Direct cardiac reprogramming: Toward the era of multi-omics analysis
Liu, M., Liu, J., Zhang, T., & Wang, L. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100058 · Cited by 6
Nandal, A., Mallon, B. S., & Telugu, B. P. V. L. (2017) · Journal of Visualized Experiments · doi:10.3791/56260 · Cited by 5
Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave
Sharp, B., Rallabandi, R., & Devaux, P. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00599-x · Cited by 5
Pereyra, A. S., & Hereu, C. (2013) · InTech eBooks · doi:10.5772/56869 · Cited by 5
The Efficacy and Safety of Sendai Viral Reprograming of Mouse Primary Cells Using Human Vectors
Tarnawski, L., Eugster, E., DeCamp, L. M., & Jovinge, S. V. (2019) · Cellular Reprogramming · doi:10.1089/cell.2018.0048 · Cited by 4
Liu, D., Haider, K. H., & Guo, C. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_27 · Cited by 3
CRISPR/Cas9 Editing in Induced Pluripotent Stem Cells: A Way Forward for Treating Cystic Fibrosis?
Quiroz, E. J., & Ryan, A. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-29403-8_9 · Cited by 3
Xiong, Y., Liu, Y., & Ge, J. (2018) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20180075 · Cited by 3
Kuczynska, Z., Neglur, P. K., Metin, E., Liput, M., Zychowicz, M., Zayat, V., Krześniak, N. E., Bużańska, L., & Kot, M. (2024) · Folia Neuropathologica · doi:10.5114/fn.2024.134026 · Cited by 3
Li, J., Cheng, M. L., Tian, W.-C., & Zhang, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2272 · Cited by 2
Wang, T., Liu, J., Chen, J., & Qin, B. (2022) · PubMed Central · doi:10.22074/cellj.2022.557559.1072 · Cited by 2
Khandani, B., & Movahedin, M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10662-7 · Cited by 2
Efficient and reliable measles reprogramming platform for the generation of human iPSC
Vashistha, S., Hoffer, S., Dade, J., Majerus, S., Royster, A., Caya, C., Sharp, B., & Devaux, P. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201723 · Cited by 2
Lieu, P. T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2848-4_5 · Cited by 2
Self-citationPreskey, D. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 2
Khan, M., Zende, S., Vaidyanath, A., Avatade, R., & Shiras, A. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101506 · Cited by 2
Engineering Cardiovascular Regeneration
Vollert, I., Eder, A., Hansen, A., & Eschenhagen, T. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-015-0010-8 · Cited by 1
The support of undifferentiated human embryonic stem cell lines by different matrices
Khadun, S. (2014) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.14447 · Cited by 1
In Vitro Methods for Generating Induced Pluripotent Stem Cells
Ahmed, T. A., Elshenawy, S. E., Essawy, M., Mohamed, R. H., & El‐Badri, N. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-55359-3_9 · Cited by 1
Reinholt, B. M. (2015) · VTechWorks (Virginia Tech) · Cited by 1
Tapponnier, Y. (2015) · theses.fr (ABES) · doi:10.70675/7812c7cez92e4z42b0z98e1z65e4915fa08a · Cited by 1
DeBose, M., Choi, J., Ding, D., Griggs, A., Gollatz, E. M., Scislowicz, E., Harbuzariu, A., & Itzhaki, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083588 · Cited by 1
INDUCED PLURIPOTENT STEM CELLS AND THEIR IMPLICATION FOR BIOMEDICAL SCIENCES
Csöbönyeiová, M. (2013) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2013.106.114 · Cited by 1
Liu, D., Haider, K. H., & Guo, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_27-1
Advances in Biotechnology for Diabetes Research and Therapy
Nandakumar, M., Darwish, R., Butler, A. E., & Moin, A. S. M. (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-3612-2_9
Lavoie, J. R. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3044
Induced pluripotent stem cells for modeling of Rett Syndrome
Shekhar, B. R., & Das, D. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00014-4
Pluripotent Stem Cells in Myocardial Tissue Engineering and Heart Regeneration
Yusof, N. A. N. M., Esa, E., & Tan, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00084-6
Hepatocyte-Like Cells Derived from Pluripotent Stem Cells
Li, Y., Polgár, Z., Roy‐Chowdhury, N., & Roy‐Chowdhury, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00019-1
Potta, S. P., Šarić, T., Heke, M., & Hescheler, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_23
Cellular models of human brain disorders from skin to brain
Shahsavani, M. (2018) · Figshare
A hPSCs-based model to study the biology of the schizophrenia and autism risk gene CYFIP1
Tamburini, C. (2018) · ORCA Online Research @Cardiff (Cardiff University)
Zulkifli, N. S., Rahim, S. A., & Muhamad, M. (2025) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.2102010
A Patient-Derived Stem Cell Model of Hereditary Spastic Paraplegia with SPAST mutations
Wali, G. (2016) · Griffith Research Online · doi:10.25904/1912/3051
Duncan, G. (2017) · Nottingham ePrints (University of Nottingham)
低分子化合物と無血清培地を用いた多能性幹細胞からの骨芽細胞分化誘導法の開発
Kanke, K. (2015) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00008412
EFFICIENT AND RELIABLE MEASLES REPROGRAMMING PLATFORM FOR THE GENERATION OF HUMAN IPSC
Vashistha, S., Hoffer, S., Jessica, D., Carter, C., Brenna, S., Spencer, M., Austin, R., & Devaux, P. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.03.469
Knock-in gene correction of induced pluripotent stem cells from pyruvate kinase deficient patient
Mutiloa, Z. G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- MacArthur, C. C., Fontes, A., Ravinder, N., Kuninger, D., Kaur, J., Bailey, M., Taliana, A., Vemuri, M. C., & Lieu, P. T.
- Affiliations
- Primary and Stem Cell Systems, Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008, USA
- Molecular and Cell Biology, Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008, USA
- Primary and Stem Cell Systems, Life Technologies Corporation, 7335 Executive Way, Frederick, MD 21704, USA
- Corresponding author
- Lieu, Pauline T.
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-9
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC3328201
- OpenAlex
- W2060090280
- Cited by
- 91
- References
- 29
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 12 · 2017: 3 · 2016: 1 · 2015: 12 · 2014: 13 · 2013: 7 · 2012: 4
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Life Technologies Corporation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, transgene-free iPSCs, feeder-free culture, xeno-free culture, somatic cell reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.